We are pleased to announce the first instalment of our 2024 Latin American regional program to address specific local challenges for physicians treating people with CML. We are starting this year's progam of three zoom-based Regional Discussion Groups on June 27th.

The Latin Amercan iCMLf Regional Discussion Groups offer a unique opportunity for CML physicians across Latin America to discuss case-related questions with International and Regional CML experts. 

Meeting 1: Thursday June 27th

Meeting 1 Topics:

• A debate - Treatment Free Remission vs Dose-reduction as a pathway to stopping therapy   

Registration now closed

Recording of the session available to watch here.

Meeting 2: Thursday August 8th

Meeting 2 Topics:

• Tyrosine kinase inhibitor (TKI) choice and sequencing of treatment in a world of increasing options
• Managing the chronic effects of TKI treatment

Register here

Meeting 3: Thursday September 12th

Meeting 3 Topics:

• 2023 ELN Laboratory Recommendations – challenges in low- and middle-income countries
  Addressing key questions and issues for Latin America, including:

• • BCR::ABL1 testing – when and how and monitoring
  • BCR::ABL1 mutation testing – when and how
  • Establishing high-quality laboratories when resources are limited

Register here

 
Timings for all meetings - 1-1.5 hours on Zoom beginning at:

• Mexico City, Mexico.  1700

• Bogota, Colombia.  1800

• Santiago, Chile.  1900 (meeting 3, 2000)

• Buenos Aires, Argentina.  2000

• Rio de Janiero, Brazil.  2000

If you’re a physician treating people with CML in Latin America, we’d love for you to join us to expand your knowledge, connect with like-minded professionals and foster further collaboration in the field of CML.

Supported by a grant from Novartis.